Robert Plenge tapped to run immunology R&D at Celgene; Tesaro files LAG-3 IND
→ Robert Plenge is taking the plunge at Celgene. The ex-Merck investigator is moving out of Big Pharma to take charge of immunology research for the big biotech.
— Bruce Booth (@LifeSciVC) April 30, 2017
→ President Trump had hoped to cut NIH spending this year as he looked for cash to build a wall with Mexico, among other things. But Congress isn’t having any of it. Lawmakers agreed to a $2 billion increase for the NIH in a spending bill agreed to by Democrats and Republicans late Sunday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.